๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Effect of Tamoxifen and Aromatase Inhibitors on the Risk of Fractures in Women with Breast Cancer

โœ Scribed by Peter Vestergaard; Lars Rejnmark; Leif Mosekilde

Publisher
Springer
Year
2008
Tongue
English
Weight
166 KB
Volume
82
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Use of aromatase inhibitors in postmenop
Use of aromatase inhibitors in postmenopausal women with advanced breast cancer
โœ Roseman, Barry J.; Buzdar, Aman U.; Singletary, S. Eva ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 39 KB ๐Ÿ‘ 2 views

Surgeons have been involved in the management of metastatic breast cancer since the technique of ovarian ablation was introduced in 1896. However, as newer hormonal and chemotherapeutic regimens were developed, drug therapy gradually replaced surgery as the preferred treatment for metastatic breast

Summary of aromatase inhibitor clinical
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer
โœ Aman U. Buzdar; R. Charles Coombes; Paul E. Goss; Eric P. Winer ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 115 KB

Five years of adjuvant therapy with tamoxifen was considered the gold-standard treatment for postmenopausal women with estrogen receptor-positive breast cancer for many years. Data from a core group of clinical trials investigating the safety and efficacy of aromatase inhibitors (AIs) have challenge